|
|||||
|
|
Cover Picture: Discovery of Riociguat (BAY 63‐2521): A Potent,Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension (ChemMedChem 5/2009) |
|
| Authors: | Joachim Mittendorf Prof. Dr. Stefan Weigand Dr. Cristina Alonso‐Alija Dr. Erwin Bischoff Dr. Achim Feurer Dr. Michael Gerisch Dr. Armin Kern Dr. Andreas Knorr Dr. Dieter Lang Dr. Klaus Muenter Dr. Martin Radtke Dr. Hartmut Schirok Dr. Karl‐Heinz Schlemmer Dr. Elke Stahl Dr. Alexander Straub Dr. Frank Wunder Dr. Johannes‐Peter Stasch Dr. |
| Affiliation: | 1. Bayer Schering Pharma AG, Medicinal Chemistry Wuppertal, 42096 Wuppertal (Germany), Fax: (+49)?202‐364490;2. Current address: Roche, Nonnenwald 2, 82377 Penzberg (Germany);3. Bayer Schering Pharma AG, Cardiovascular Research, 42096 Wuppertal (Germany);4. Current address: Santhera Pharmaceuticals Ltd. Hammerstrasse 47, 4410 Liestal (Switzerland);5. Bayer Schering Pharma AG, DMPK, 42096 Wuppertal (Germany) |
| Abstract: | |
| Keywords: | BAY 63‐2521 pulmonary hypertension riociguat sGC stimulation vasorelaxation |